Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 89%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
29,809
Total Claims
$2.5M
Drug Cost
994
Beneficiaries
$2,547
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-45%
Opioid rate vs peers
1.4% vs 2.6% avg
+139%
Cost per patient vs peers
$2,547 vs $1,068 avg
+123%
Brand preference vs peers
20.1% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.4%
Opioid Rate
420
Opioid Claims
$11K
Opioid Cost
11.2%
Long-Acting Rate
Brand vs Generic
Brand: 5,960 claims · $1.7M
Generic: 23,735 claims · $856K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 1,357 | $386K |
| Tolvaptan | 20 | $101K |
| Dulaglutide | 115 | $82K |
| Rivaroxaban | 287 | $81K |
| Insulin Glargine,hum.Rec.Anlog | 266 | $70K |
| Pimavanserin Tartrate | 29 | $68K |
| Semaglutide | 58 | $60K |
| Dimethyl Fumarate | 12 | $54K |
| Linagliptin | 186 | $49K |
| Empagliflozin | 156 | $48K |
| Fluticasone/Umeclidin/Vilanter | 91 | $46K |
| Sitagliptin Phosphate | 161 | $44K |
| Mirabegron | 155 | $40K |
| Methylnaltrexone Bromide | 45 | $36K |
| Potassium Chloride | 885 | $31K |
Prescribing Profile
Patient Profile
80
Avg Age
65%
Female
2.42
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About